Atopik Dermatit Tedavisi

Öz

Atopik dermatit AD ; prevalansı ve insidansı özellikle batı ülkelerinde artış gösteren, derinin karmaşık, kronik olarak tekrarlayıcı inflamatuvar bir hastalığıdır. Hastalar ve aileleri üzerinde belirgin bir ekonomik yük ve morbiditeye sahiptir. infantil ekzemaların en sık görülen formudur ve 5 yana kadar çocukların yaklaşık %10-15’inde klinik tablo yerleşmektedir 1,2 . AD zaman içinde spontan iyileşebilmekle beraber atopik hastaların %30 ila %80’ninde yaşamın ileri dönemlerinde özellikle emosyonel ve fiziksel stresle alevlenmeler görülebilir 2 .

Kaynakça

1. 1. Kang K, Polster AM, Nedorost ST. Atopic Dermatitis. In: Bolognia JL, Jorizzo JL, Rapini RP (eds). Dermatology. 1st ed. Toronto: Mosby Comp; 2003. p.199.
2. 2. Pajno GB, Peroni DG, Barberio G, Pietrobelli A, Boner AL: Predictive features for persistence of atopic dermatitis in children. Pediatr All Immunol 2003; 14: 292-95.
3. 3. Stander S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002; 11: 12-24.
4. 4. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92:44-7
5. 5. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dematol 2003; 6: 1088-95.
6. 6. Banon ED, Banzilai D, Johnston G, Kawashima M, Takigawa M, Nakagawa H, Graham-Brown RAC, Stevens SR. Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, USA and UK. Br J Dermatol 2002; 147:710-15
7. 7. Hanifin JM, Tofte SJ. Update on therapy for atopic dermatitis. J Allergy Clin Immunol 1999; 3: 123-5.
8. 8. Mori M, Pimpinelli N, Giannotti B. Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio. Drug Saf 1994; 10: 406-12.

9. 9. Charman C, Williams H. The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol 2003; 21: 193-200.
10. 10. Clayton MH, Leung DYM, Surs W et al. Altered glucocoticoid binding in atopic dermatitis. J Allergy Clin Immunol 1995; 96: 412-3.
11. 11. Art›k S, Ruzicka T. Complementary therapy for atopic eczema and other allergic skin diseases. Dermatol Ther 2003; 16: 150-63.
12. 12. Prinz B, Michelsen S, Pfeiffer C, Plewig G. Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol 1999; 40: 577-82.
13. 13. Tomi NS, Luger TA. The treatment of atopic dermatitis with topical immunomodulators. Clin Dermatol 2003; 21: 215-24.
14. 14. Schneider LC. New treatments for atopic dermatitis. Immunol Allergy Clin North Am 2002; 22: 141-52.
15. 15. Kawashima M, Nakagawa H, Ohtsuki M. Tacrolimus concentrations in blood during topical treatment of atopic dermatitis. Lancet 1996; 348: 1240-1.
16. 16. Peritamo S, Wollenberg A, Schopf E. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis: the European Tacrolimus Ointment Study Group. Arch Dermatol 1998; 38: 69-76.
17. 17. Eichenfield LF, Beck L. Elidel (pimecrolimus) cream 1%: a nonsteroid topical agent for the treatment of atopic dermatitis. J Allergy Clin Immunol 2003; 111: 1153-68.
18. 18. Boguniewicz M, Nicol N. Conventional therapy for atopic dermatitis. Immunol Allergy Clin North Am 2002; 22: 107-124.
19. 19. Wahlgren CF, Hagermark Ö, Bergström R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol 1990; 122: 545-51.
20. 20. Scheinfeld NS, Tutrone WD, Weinberg JM, Delea VA. Phototherapy of atopic dermatitis. Clin Dermatol 2003; 21: 241-48.
21. 21. Simon JC, Pfieger D, Schopf E. Recent advances in phototherapy. Eur J Dermatol 2000; 10: 642-5.
22. 22. Banon ED, Stevens SR. Light treatment modalities for atopic dermatitis. Immunol Allergy Clin North Am 2002; 22: 125-40.
23. 23. Grundmann –Kollmann M, Behrens S, Podda M. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999; 40: 995-7.
24. 24. Alora MB, Taylor CR. Narrow-band (311 nm) UVB phototherapy in audit of the first year’s experience at the Massachusetts General Hospital. Photodermatol Photoimmunol Photomed 1997; 13: 82-4.
25. 25. Tay YK, Morelli JG, Weston WL. Experience with UVB phototherpay in children. Pediatr Dermatol 1996; 13: 406-9.
26. 26. Akhavan A, Rudikoff D. The treatment of atopic dermatitis withsystemic immunosuppressive agents. Clin Dermatol 2003; 21: 225-40.
27. 27. Tunal› fi, Sar›cao¤lu H, Özy›ld›r›m R, Alpagut fi. Atopik dermatit tedavisinde siklosporin A ile elde edilen sonuçlar. Turkderm 1997; 31: 32-4.
28. 28. Stevens SR, Hanifin JM, Hamilton T, Tofte SJ, Cooper KD. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch Dermatol 1998; 134: 799-804.
29. 29. Jolles S, Hughesd J, Rustin M. The treatment of atopic dermatitis with adjunctive high dose immunoglobulin: A report of three patients and review of literature. Br J Dermatol 2000; 142: 551-4.
30. 30. Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE. The leucotrien antagonist zafirlukast as a theurapeutic agent for atopic dermatitis. Arch Dermatol 1998; 134: 785-6.